| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $33,504,819 ) (Continued on the next page) |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA249501 | Self-Management to Optimize Survivorship Care and Outcomes in Lung and Colorectal Cancer | 000 | 3 | NIH | 4/8/2022 | $821,715 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R33AG059206 | Geriatric Oncology Research Infrastructure to Improve Clinical Care | 000 | 5 | NIH | 5/18/2022 | $847,027 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA249460 | Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers | 000 | 3 | NIH | 3/21/2022 | $740,719 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA249460 | Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers | 001 | 3 | NIH | 5/9/2022 | $65,843 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK124627 | Bile acids and metabolic surgery | 000 | 3 | NIH | 5/23/2022 | $396,000 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | U01CA250046 | Information flow and state transitions at the system and multi-dimensional scales in leukemia progression | 001 | 3 | NIH | 5/20/2022 | $700,616 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA244576 | Overcoming ibrutinib resistance in mantle cell lymphoma | 001 | 2 | NIH | 4/29/2022 | $36,075 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA244576 | Overcoming ibrutinib resistance in mantle cell lymphoma | 000 | 2 | NIH | 1/31/2022 | $405,856 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01LM013138 | Scalable Bayesian Network analysis of multimodal FACS and SUMOylation data, with generalization to other big mixed biological datasets | 000 | 3 | NIH | 2/25/2022 | $261,800 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA247550 | Characterizing and Targeting the Novel IL-15- AKT-XBP1s Pathway in NK Cells | 000 | 3 | NIH | 11/4/2021 | $401,118 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA247550 | Characterizing and Targeting the Novel IL-15- AKT-XBP1s Pathway in NK Cells | 001 | 3 | NIH | 5/5/2022 | $35,654 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01HL150069 | Cardiovascular reserve capacity in survivors of hematopoietic cell transplantation | 000 | 3 | NIH | 1/29/2022 | $621,065 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA248149 | Role of Protein Arginine Methyltransferase 9 in Acute Myeloid Leukemia Maintenance | 001 | 3 | NIH | 4/27/2022 | $34,682 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA248149 | Role of Protein Arginine Methyltransferase 9 in Acute Myeloid Leukemia Maintenance | 000 | 3 | NIH | 2/28/2022 | $390,163 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA248475 | Vascular Remodeling in the Bone Marrow Leukemic Niche: A Therapeutic Target? | 000 | 3 | NIH | 3/31/2022 | $500,361 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA240910 | Cooperation of SF3B1 mutations and ATM deletions in the pathogenesis of chronic lymphocytic leukemia | 001 | 3 | NIH | 5/12/2022 | $34,598 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA240910 | Cooperation of SF3B1 mutations and ATM deletions in the pathogenesis of chronic lymphocytic leukemia | 000 | 3 | NIH | 3/25/2022 | $389,186 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA233664 | DNA repair gene mutations and prostate cancer | 001 | 3 | NIH | 4/29/2022 | $55,820 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | P30CA033572 | Cancer Center Support Grant | 001 | 39 | NIH | 3/8/2022 | $115,000 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA085344 | Dynamic functions of DNA2 counteract DNA replication stresses and tumorigenesis | 000 | 23 | NIH | 5/4/2022 | $326,744 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01HL106089 | Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells | 002 | 11 | NIH | 4/8/2022 | $703,887 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01GM117923 | Structural dynamics underlying GPCR-G protein selectivity | 000 | 6 | NIH | 2/1/2022 | $316,800 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA154491 | Conformal Total Body and Marrow Irradiation for Leukemia | 000 | 9 | NIH | 12/23/2021 | $631,113 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA154491 | Conformal Total Body and Marrow Irradiation for Leukemia | 001 | 9 | NIH | 4/27/2022 | $56,100 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R25CA171998 | Cancer Genetics Professional Education in a Global Community of Practice | 000 | 9 | NIH | 5/27/2022 | $42,144 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01AI109644 | Steroid nuclear receptor coactivators in T cell differentiation | 000 | 9 | NIH | 3/24/2022 | $510,194 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | K24AG055693 | Mentoring the Next Generation of Geriatric Oncology Researchers in Patient-Oriented Research to Improve the Care of Older Adults with Cancer | 000 | 5 | NIH | 11/24/2021 | $129,952 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK102233 | Targeting an atypical signaling hub to restore and protect whole body glucose homeostasis | 001 | 6 | NIH | 11/24/2021 | $396,000 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK102233 | Targeting an atypical signaling hub to restore and protect whole body glucose homeostasis | 002 | 6 | NIH | 4/21/2022 | $44,000 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK104941 | Androgen Signaling in Prostatic Sonic Hedgehog Responsive Cells | 000 | 6 | NIH | 5/27/2022 | $387,200 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA243386 | Targeting FTO to treat acute myeloid leukemia | 000 | 3 | NIH | 11/24/2021 | $513,273 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA243386 | Targeting FTO to treat acute myeloid leukemia | 001 | 3 | NIH | 5/13/2022 | $45,625 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | T32CA186895 | DNA Damage Response and Oncogenic Signaling | 001 | 6 | NIH | 2/21/2022 | $200,853 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA233922 | Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy | 000 | 4 | NIH | 11/12/2021 | $622,665 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA233922 | Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy | 001 | 4 | NIH | 4/22/2022 | $55,349 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01NS106170 | Overcoming Barriers of Virotherapy by Next-Generation oHSV Expressing E-Cadherin | 001 | 4 | NIH | 3/31/2022 | $37,491 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01NS106170 | Overcoming Barriers of Virotherapy by Next-Generation oHSV Expressing E-Cadherin | 000 | 4 | NIH | 12/29/2021 | $337,421 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA228465 | PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activity | 000 | 5 | NIH | 2/28/2022 | $356,338 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA228465 | PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activity | 001 | 5 | NIH | 5/19/2022 | $31,675 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R37CA233691 | Combinational targeting the feed forward epigenetic circuitry in mixed lineage leukemia | 000 | 4 | NIH | 11/24/2021 | $356,164 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R37CA233691 | Combinational targeting the feed forward epigenetic circuitry in mixed lineage leukemia | 001 | 4 | NIH | 4/29/2022 | $39,574 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01HL141336 | Targeting protein acetylation as a therapeutic approach for MDS | 000 | 5 | NIH | 2/24/2022 | $389,250 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R25CA233431 | Yes 2 Success | 000 | 4 | NIH | 2/15/2022 | $485,999 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK120523 | Regulation of beta-cell homeostasis by DNA methylation and hydroxymethylation. | 000 | 4 | NIH | 1/28/2022 | $389,250 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK120523 | Regulation of beta-cell homeostasis by DNA methylation and hydroxymethylation. | 001 | 4 | NIH | 4/7/2022 | $43,250 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA229510 | Cutaneous T cell lymphoma: a paradigm for dissecting susceptibility and resistance to checkpoint inhibition therapy | 000 | 4 | NIH | 3/1/2022 | $507,288 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA229510 | Cutaneous T cell lymphoma: a paradigm for dissecting susceptibility and resistance to checkpoint inhibition therapy | 001 | 4 | NIH | 5/25/2022 | $45,095 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA236626 | Role of BAZ2A in MLL-r leukemia and therapeutic response | 000 | 4 | NIH | 3/17/2022 | $356,164 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA236626 | Role of BAZ2A in MLL-r leukemia and therapeutic response | 001 | 4 | NIH | 6/17/2022 | $39,574 |
|
